SBRA Insider Trading Activity and SEC Form 4 Filings
SBRA insider trading summary
No open-market insider purchases or sales of Sabra Health Care REIT, Inc. (SBRA) have been reported on SEC Form 4 in the past 12 months.
Latest SBRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 20, 2025 | Michael J Foster | Director | Sell | $200K (11,000 @ $18.22) |
| Feb 24, 2025 | Catherine Cusack | Director | Buy | $24K (1,500 @ $15.92) |
| Feb 21, 2025 | Catherine Cusack | Director | Buy | $16K (1,000 @ $16.43) |
| May 22, 2024 | Catherine Cusack | Director | Buy | $101K (7,000 @ $14.43) |
| May 14, 2024 | Michael J Foster | Director | Sell | $147K (10,000 @ $14.68) |
| Sep 1, 2023 | Michael Lourenco Costa | Executive VP, CFO & Secretary | Buy | $25K (1,947 @ $12.63) |
| Dec 29, 2021 | Harold W. Andrews Jr. | Executive VP, CFO & Secretary | Sell | $1.5M (110,000 @ $13.55) |
| May 13, 2021 | Catherine Cusack | Director | Buy | $34K (2,000 @ $17.19) |
| Mar 4, 2021 | Michael J Foster | Director | Sell | $52K (3,000 @ $17.39) |
| Mar 4, 2021 | Michael J Foster | Director | Sell | $52K (3,000 @ $17.48) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.